Societies Issue Three-Part Compendium on Female Heart Health tctmd.com/news/societies-iss…
Pulmonary embolism may have a connection with atherosclerotic cardiovascular disease—a recent analysis of US data shows that PE-attributed deaths are on the rise among ASCVD patients, especially for younger adults and racial/ethnic minority groups. bit.ly/4e0H4wZ
New evidence suggests that blood-pressure drops during stroke thrombectomy are associated with worse functional recovery. The findings highlight a critical consideration for teams treating large-vessel occlusion stroke. bit.ly/47opdfP
TCTMD retweeted
🔥 Four days to go!
The conversations, discoveries, and innovations that will drive cardiovascular care forward are just around the corner.
Be part of the experience everyone will be talking about. 👉 Register for #TCT2026! ow.ly/2SAz50ZXmMw
#CardioX #CardioTwitter #CardioEd #CardioResearch @BurkhoffMd @djc795 @ColletCarlos @georgedangas @jgranadacrf @mbmcentegart @Drroxmehran @sahilparikhmd @PopmaJeffrey @triciarawh @mirvatalasnag @TCTConference @TCTMD @m1chaella_alex @CathWhisperer @caldera_99 @SinaDaneshMD @CAESmedmd @Julio_Farjat @GolzarianH @JyotiJain_MD @Shikha_Cardio @DrBilal_khan @KrutarthKPandya @Shoaib9702 @IoannisSkalidis @Sticchi_Alex @ricosuruagy @ladyheart_md @AnaClaraVi75147 @anast_apost @padideh_daneii
Edwards Lifesciences has pulled certain lots of its Sapien M3 delivery system following reports of balloons bursting during TMVR. The issue has been associated with one death and one serious injury, according to an FDA early alert. bit.ly/4k0MsUs
Please join us in welcoming Bailey Salimes (@TCTMD_Bailey) to the @TCTMD team! Bailey joins us as a Medical Journalist and will be on site at #TCT2026 this weekend. We’re excited to welcome her aboard and look forward to sharing her reporting with our community. Attending TCT? Be sure to say hello!
TCTMD retweeted
✋ Just 5 days until #TCT2026!
From late-breaking trials and live cases to cutting-edge technologies and meaningful connections, an unforgettable experience is almost here.
Haven't registered yet?
👉 Secure your spot now! ow.ly/vR4H50ZXmmW
#CardioX #CardioTwitter #CardioEd #CardioResearch @BurkhoffMd @djc795 @ColletCarlos @georgedangas @jgranadacrf @mbmcentegart @Drroxmehran @sahilparikhmd @PopmaJeffrey @triciarawh @mirvatalasnag @TCTConference @TCTMD @m1chaella_alex @CathWhisperer @caldera_99 @SinaDaneshMD @CAESmedmd @Julio_Farjat @GolzarianH @JyotiJain_MD @Shikha_Cardio @DrBilal_khan @KrutarthKPandya @Shoaib9702 @IoannisSkalidis @Sticchi_Alex @ricosuruagy @ladyheart_md @AnaClaraVi75147 @anast_apost @padideh_daneii
A potential new role for SGLT2 inhibitors in ANOCA? Empagliflozin was associated with improved angina for these patients in a small pilot study and might even help reverse endothelial dysfunction, though experts caution that the findings are preliminary. bit.ly/4ySBapY
Closing the gaps in PAD care will require more than earlier detection.
Experts at #VIVA2026 emphasized the need to shift from reactive treatment to earlier detection and prevention, pointing to AI, targeted screening, and policy changes as potential avenues to improve vascular care and limb preservation. bit.ly/4sbdPNR
Early Signs of Vascular, Cardiorespiratory Problems Seen in Regular Vape Users bit.ly/4Bloo52
New observational data suggest that PCI within 24 hours may be associated with worse outcomes than a delayed approach, highlighting the opportunity to pause, optimize medical therapy, and then make a decision about revascularization. bit.ly/4jnbAEW
What does it mean to leave cardiac care better for the next generation? In TCTMD’s Hearts & Minds podcast, John D. Puskas joins @TCTMD_Yael for a conversation about the values that guide his work and the drive to keep advancing the field. Listen to the full episode: bit.ly/4sjiEoh
#HeartsAndMinds #CardiacSurgery
TCTMD retweeted
⏳ Short on time? You don't have to miss out on the world's premier forum in interventional cardiovascular medicine.
✨ Choose the day that fits your schedule and experience the science, innovation, and leaders shaping the future of care! ow.ly/BT9v50ZYCzb
#CardioX #CardioTwitter #CardioEd #CardioResearch @BurkhoffMd @djc795 @ColletCarlos @georgedangas @jgranadacrf @mbmcentegart @Drroxmehran @sahilparikhmd @PopmaJeffrey @triciarawh @mirvatalasnag @TCTConference @TCTMD @m1chaella_alex @CathWhisperer @caldera_99 @SinaDaneshMD @CAESmedmd @Julio_Farjat @GolzarianH @JyotiJain_MD @Shikha_Cardio @DrBilal_khan @KrutarthKPandya @Shoaib9702 @IoannisSkalidis @Sticchi_Alex @ricosuruagy @ladyheart_md @AnaClaraVi75147 @anast_apost @padideh_daneii
The Viabahn VBX, sold in the US for nearly a decade, is now the first and only FDA-approved bridging stent graft for use in FEVAR and BEVAR. bit.ly/47j2BgE
The wait is over—it’s John Puskas! 🎧
Surgeon, researcher, inventor, and educator John Puskas joins @TCTMD_Yael in the latest episode of TCTMD’s Hearts & Minds podcast for a conversation about knowledge sharing, new ways of thinking, and advances in surgical coronary revascularization. Plus, did you know he’s a pilot?
Listen to the full episode: bit.ly/486dOkS
#CardiacSurgery
Heart failure care has advanced, but the US burden continues to grow. A new report shows mortality is rising as more Americans are being affected, with obesity, diabetes, and other comorbidities potentially contributing to the trend. #HeartFailure #PublicHealth bit.ly/4rZGy8a
